WA
ZVSAW

Whitebox Advisors’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Whitebox Advisors’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-132,675
Closed -$16K – 880
2022
Q3 		$16K Hold
132,675
– – ﹤0.01% 601
2022
Q2 		$14K Hold
132,675
– – ﹤0.01% 620
2022
Q1 		$23K Buy
+132,675
New +$26.9K ﹤0.01% 688

Whitebox Advisors's ZVSAW Position: Q4 2022 in Review

Whitebox Advisors sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 132,675 shares — an estimated $16K sold.

Whitebox Advisors first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $23K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • Whitebox Advisors reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • Whitebox Advisors sold 132,675 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $16K.
  • Whitebox Advisors first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
  • Whitebox Advisors's ZyVersa Therapeutics, Inc. Warrants position peaked at $23K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Whitebox Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.